The crucial role and mechanism of insulin resistance in metabolic disease
X Zhao, X An, C Yang, W Sun, H Ji… - Frontiers in endocrinology, 2023 - frontiersin.org
Insulin resistance (IR) plays a crucial role in the development and progression of
metabolism-related diseases such as diabetes, hypertension, tumors, and nonalcoholic fatty …
metabolism-related diseases such as diabetes, hypertension, tumors, and nonalcoholic fatty …
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association
SD De Ferranti, IH De Boer, V Fonseca, CS Fox… - Circulation, 2014 - Am Heart Assoc
(CVD) in individuals with type 1 diabetes mellitus (T1DM), the pathophysiology underlying
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …
Insulin resistance and hyperglycaemia in cardiovascular disease development
M Laakso, J Kuusisto - Nature reviews endocrinology, 2014 - nature.com
The prevalence of diabetes mellitus will likely increase globally from 371 million individuals
in 2013 to 552 million individuals in 2030. This epidemic is mainly attributable to type 2 …
in 2013 to 552 million individuals in 2030. This epidemic is mainly attributable to type 2 …
Insulin resistance is a cardiovascular risk factor in humans
MM Adeva-Andany, J Martínez-Rodríguez… - Diabetes & Metabolic …, 2019 - Elsevier
Diabetes is a common metabolic disorder associated to elevated cardiovascular morbidity
and mortality that is not explained by hyperglycemia or traditional cardiovascular risk factors …
and mortality that is not explained by hyperglycemia or traditional cardiovascular risk factors …
Obesity in people living with type 1 diabetes
B Van der Schueren, D Ellis, RN Faradji… - The Lancet Diabetes & …, 2021 - thelancet.com
Although type 1 diabetes is traditionally considered a disease of lean people, overweight
and obesity are becoming increasingly more common in individuals with type 1 diabetes …
and obesity are becoming increasingly more common in individuals with type 1 diabetes …
Prevention of Cardiovascular Disease in Type 1 Diabetes
C Manrique-Acevedo, IB Hirsch… - New England Journal of …, 2024 - Mass Medical Soc
Prevention of Cardiovascular Disease in Type 1 Diabetes | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Pathogenesis of lipid disorders in insulin resistance: a brief review
P Bjornstad, RH Eckel - Current diabetes reports, 2018 - Springer
Purpose of review Insulin resistance (IR) is recognized to play an important role in the
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …
Diabetes and beta cell function: from mechanisms to evaluation and clinical implications
S Cernea, M Dobreanu - Biochemia medica, 2013 - hrcak.srce.hr
Sažetak Diabetes is a complex, heterogeneous condition that has beta cell dysfunction at its
core. Many factors (eg hyperglycemia/glucotoxicity, lipotoxicity, autoimmunity, inflammation …
core. Many factors (eg hyperglycemia/glucotoxicity, lipotoxicity, autoimmunity, inflammation …
Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?
SJ Cleland, BM Fisher, HM Colhoun, N Sattar… - Diabetologia, 2013 - Springer
In this review, we explore the concept of 'double diabetes', a combination of type 1 diabetes
with features of insulin resistance and type 2 diabetes. After considering whether double …
with features of insulin resistance and type 2 diabetes. After considering whether double …
Double diabetes: a distinct high‐risk group?
N Kietsiriroje, S Pearson, M Campbell… - Diabetes, Obesity …, 2019 - Wiley Online Library
The term double diabetes (DD) has been used to refer to individuals with type 1 diabetes
(T1D) who are overweight, have a family history of type 2 diabetes and/or clinical features of …
(T1D) who are overweight, have a family history of type 2 diabetes and/or clinical features of …